Cytopag 50 Tablet

About Cytopag 50 Tablet

Cytopag 50 50 mg is a tablet product of Advanced Chemical Industries PLC that contains Eltrombopag. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

There are 7 brands of Eltrombopag listed in Bangladesh.

What is Cytopag 50 Tablet?

The tablet Cytopag 50 contains Eltrombopag and is made by Advanced Chemical Industries PLC. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. The doctor decides the dose and course.

Uses of Cytopag 50

For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy. Your doctor will decide if it is suitable for you.

How to use Cytopag 50

Cytopag 50 is taken by mouth. Swallow the tablet with water. Do not attempt to use it yourself. Do not change the dose or stop early without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Cytopag 50

He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity. Ask your doctor first if any of these apply to you.

Frequently asked questions

Why is Cytopag 50 prescribed?

For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.

How should I take Cytopag 50?

Cytopag 50 is taken by mouth. Swallow the tablet with water.

What are the side effects of Cytopag 50?

He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away.

Can I use Cytopag 50 in pregnancy or while breastfeeding?

The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity.

Alternative brands of Eltrombopag

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.